Craft

Boston Scientific

Stock Price

$84.5

2024-10-02

Market Capitalization

$124.4 B

2024-10-02

Revenue

$14.2 B

FY, 2023

Boston Scientific Summary

Company Summary

Overview
Boston Scientific is a developer, manufacturer, and marketer of medical devices. It offers pacemakers, defibrillators, left atrial appendage closure devices, single-use scopes, spinal cord stimulator systems, coronary stents, and other products. The company also provides treatments and therapies such as surgery, chemotherapy, radiation therapy, enteral feeding, cardiac monitoring, radiofrequency ablation, etc.
Type
Public
Status
Active
Founded
1979
HQ
Marlborough, MA, US | view all locations
Website
https://www.bostonscientific.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Michael F. Mahoney

    Michael F. Mahoney, Chairman and Chief Executive Officer

  • Dan Brennan

    Dan Brennan, Executive Vice President and Chief Financial Officer

  • Jodi Eddy

    Jodi Eddy, Senior Vice President and Chief Information and Digital Officer

  • Mary Beth Moynihan

    Mary Beth Moynihan, Senior Vice President, Market Access and Chief Marketing Officer

Operating MetricsView all

Countries

130
8.3%

FY, 2022

Medical Institutions Covered (U.S.)

36K
2.9%

FY, 2022

Manufacturing Facilities

15
6.3%

FY, 2022

LocationsView all

34 locations detected

  • Marlborough, MA HQ

    United States

    300 Boston Scientific Way

  • Alpharetta, GA

    United States

    11810 Wills Rd

  • Maple Grove, MN

    United States

    1 Scimed Pl

  • Spencer, IN

    United States

    780 Brookside Dr

  • St. Paul, MN

    United States

    4100 Hamline Ave N

  • Washington, DC

    United States

    1455 Pennsylvania Avenue, NW, Suite 925

and 28 others

Boston Scientific Financials

Summary Financials

Revenue (Q2, 2024)
$4.1B
Gross profit (Q2, 2024)
$2.9B
Net income (Q2, 2024)
$322.0M
Cash (Q2, 2024)
$2.9B
EBIT (Q2, 2024)
$520.0M
Enterprise value
$132.1B

Footer menu